4//SEC Filing
Hurvitz Chaim 4
Accession 0001415889-23-013137
CIK 0001719406other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 9:15 AM ET
Size
6.9 KB
Accession
0001415889-23-013137
Insider Transaction Report
Form 4
Hurvitz Chaim
Director
Transactions
- Purchase
Common Stock, par value $0.001 per share
2023-08-30$0.29/sh+70,000$20,125→ 570,000 total
Holdings
- 208,443(indirect: By CH Health-Private Venture Capital Ltd.)
Common Stock, par value $0.001 per share
- 1,436,350(indirect: By IRA)
Common Stock, par value $0.001 per share
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares of the Common Stock and prices at which the transaction was effected.
- [F2]Chaim Hurwitz is the owner of Shirat HaChaim Ltd.
- [F3]Chaim Hurwitz is the owner of CH Health-Private Venture Capital Ltd.
Documents
Issuer
NRX Pharmaceuticals, Inc.
CIK 0001719406
Entity typeother
Related Parties
1- filerCIK 0001630542
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 9:15 AM ET
- Size
- 6.9 KB